Can we predict the effects of NF-κB inhibition in sepsis? Studies with parthenolide and ethyl pyruvate

類似資料

• The Surviving Sepsis Campaign's Revised Sepsis Bundles
  著者:: Barochia, Amisha V., 等
  出版事項: (2013)
• Eritoran tetrasodium (E5564) Treatment for Sepsis: Review of Preclinical and Clinical Studies
  著者:: Barochia, Amisha, 等
  出版事項: (2011)
• Risk of death and the efficacy of eritoran tetrasodium (E5564): Design considerations for clinical trials of anti-inflammatory agents in sepsis(*)
  著者:: Barochia, Amisha V., 等
  出版事項: (2010)
• The evolving experience with therapeutic TNF inhibition in sepsis: considering the potential influence of risk of death
  著者:: Qiu, Ping, 等
  出版事項: (2011)
• Growing insights into the potential benefits and risks of activated protein C administration in sepsis: a review of preclinical and clinical studies
  著者:: Altaweel, Laith, 等
  出版事項: (2009)